Mustang Bio Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Cash and Cash Equivalents Quarterly16.3MTarget: Sufficient to fund operations for at least 12 months
Net Loss Quarterly-960KTarget: Minimize cash burn through lean operating structure
Stock Price (Nasdaq Compliance) Daily0.6Target: >= $1.00 for at least 10 consecutive business days
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business days (Deficiency notice received April 15, 2026)Action: Regain compliance by October 12, 2026, or implement a reverse stock split if necessary.
- Clinical Progress of MB-109Trigger: Initiation of City of Hope investigator-sponsored trial evaluating combinations of MB-101 and MB-108Action: Monitor patient enrollment and safety/efficacy data updates.
- Capital Runway and Funding ConstraintsTrigger: Constrained by 'baby shelf' limits under Form S-3 registrationAction: Explore strategic partnerships or alternative equity financing structures to extend runway beyond 12 months.
Research as of 20 Jun 2026